CYTK
Price
$67.68
Change
-$6.30 (-8.52%)
Updated
Mar 4, 6:59 PM EST
59 days until earnings call
REPL
Price
$8.88
Change
-$0.09 (-1.00%)
Updated
Mar 4, 6:59 PM EST
73 days until earnings call
Ad is loading...

CYTK vs REPL ᐉ Comparison: Which is Better to Invest?

Header iconCYTK vs REPL Comparison
Open Charts CYTK vs REPLBanner chart's image
Cytokinetics
Price$67.68
Change-$6.30 (-8.52%)
Volume$2.22M
CapitalizationN/A
Replimune Group
Price$8.88
Change-$0.09 (-1.00%)
Volume$401.26K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs REPL Comparison Chart

Loading...

CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REPLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CYTK vs. REPL commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and REPL is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (CYTK: $73.98 vs. REPL: $8.97)
Brand notoriety: CYTK and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 33% vs. REPL: 61%
Market capitalization -- CYTK: $7.25B vs. REPL: $550.65M
CYTK [@Biotechnology] is valued at $7.25B. REPL’s [@Biotechnology] market capitalization is $550.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while REPL’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 5 bearish.
  • REPL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, REPL is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -5.18% price change this week, while REPL (@Biotechnology) price change was +8.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.19%. For the same industry, the average monthly price growth was +19.18%, and the average quarterly price growth was +53.54%.

Reported Earning Dates

CYTK is expected to report earnings on May 02, 2024.

REPL is expected to report earnings on May 16, 2024.

Industries' Descriptions

@Biotechnology (+4.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for REPL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($7.25B) has a higher market cap than REPL($551M). REPL YTD gains are higher at: 6.406 vs. CYTK (-11.391). REPL has higher annual earnings (EBITDA): -200.44M vs. CYTK (-462.64M). CYTK has more cash in the bank: 539M vs. REPL (466M). REPL has less debt than CYTK: REPL (75.8M) vs CYTK (748M). CYTK has higher revenues than REPL: CYTK (7.82M) vs REPL (0).
CYTKREPLCYTK / REPL
Capitalization7.25B551M1,317%
EBITDA-462.64M-200.44M231%
Gain YTD-11.3916.406-178%
P/E RatioN/AN/A-
Revenue7.82M0-
Total Cash539M466M116%
Total Debt748M75.8M987%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
12
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKREPL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
74%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REPLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSTX61.650.85
+1.40%
Putnam Global Health Care A
NWHMX9.390.10
+1.08%
Nationwide Bailard Intl Eqs R6
OWSMX15.790.14
+0.89%
Old Westbury Small & Mid Cap Strategies
MCLVX27.390.14
+0.51%
BlackRock Advantage Large Cap Val Inv C
KSMIX9.240.01
+0.11%
Keeley Small-Mid Cap Value I

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+4.55%
MDGL - REPL
56%
Loosely correlated
+6.53%
IBIO - REPL
43%
Loosely correlated
-1.59%
AXON - REPL
41%
Loosely correlated
+2.24%
EIGR - REPL
41%
Loosely correlated
+25.00%
ORMP - REPL
39%
Loosely correlated
+3.95%
More